Exactmer owns the Nanostar Sieving technology platform. This employs iterative, liquid-phase chemistry coupled to membrane purification, to create polymers of outstanding purity. Exactmer is currently advancing the production of oligonucleotides at scale, bringing these advanced therapeutics to all patients in need. Nanostar Sieving can also produce unimolecular polyethylene glycols (PEGs), including a disruptive new suite of multi-functional 'PEGabets', with handles for conjugation along the polymer backbone; ideal linkers molecules for Antibody Drug Conjugates.
Company Details
- Employees
- 29
- Founded
- -
- Address
- Londoneast-Uk Business And Technical Park, The Cube (D38 Building),united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- exactmer.com
- HQ
- Yew Tree Avenue, Dagenham
Exactmer Questions
Exactmer's website is exactmer.com
Exactmer's LinkedIn profile is https://uk.linkedin.com/company/exactmer
Exactmer has
29 employees.
View email and phone details for 29
employees at Exactmer.
Exactmer's industry is
Pharmaceutical Manufacturing
Exactmer's top competitors are
Inovia Bio,
Amphico,
Gsk,
Pharmidex,
Sygnature Discovery,
Synthomer,
Catsci Ltd,
Tuli,
Touchlight,
Anaphite.
Exactmer's categories are Pharmaceutical Manufacturing
Exactmer's founding year is 2017
